Moneta Group Investment Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Moneta Group Investment Advisors's EW Position: Q2 2026 in Review
Moneta Group Investment Advisors reduced its Edwards Lifesciences (EW) stake by 6.3% in Q2 2026, selling an estimated $58.6K and leaving 10,473 shares worth $947K. The position accounts for 0.01% of the portfolio, ranked #407.
Moneta Group Investment Advisors first reported a position in EW in Q3 2015 and has held it in 24 quarters since. The position peaked at $1.81M in Q4 2021. 1,334 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Moneta Group Investment Advisors held 10,473 shares of Edwards Lifesciences worth $947K as of Q2 2026.
- Moneta Group Investment Advisors sold 700 Edwards Lifesciences shares in Q2 2026, an estimated $58.6K.
- Edwards Lifesciences made up 0.01% of Moneta Group Investment Advisors's portfolio in Q2 2026, its #407 holding.
- Moneta Group Investment Advisors first reported a position in Edwards Lifesciences in Q3 2015 and has held it in 24 quarters since.
- Moneta Group Investment Advisors's Edwards Lifesciences position peaked at $1.81M in Q4 2021.
- 1,334 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Moneta Group Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.